In our report we characterized novel cisplatin-resistant variant of NTERA-2 and NCCIT germ cell tumor cells designated NTERA-2 CisR and NCCIT CisR with high ALDH activity previously associated with a cancer stem cell phenotype. This evidence concerns the gene LDHA and cancer.